GDRX / GoodRx Holdings, Inc. (GDRX) Q4 2022 Earnings Call Transcript

GoodRx said on Thursday it has collaborated with Sanofi to offer the drugmaker's most-prescribed insulin injection Lantus for only $35 through its dig more_horizontal

GoodRx's investment thesis is positive. The company's near-term prospects are promising. GoodRx is experiencing strong revenue growth rates. more_horizontal

GoodRx is generating solid profitability with growth in monthly active consumers to its prescription drugs discount platform. Management expects stron more_horizontal

Investors looking for stocks in the Medical Services sector might want to consider either Icon PLC (ICLR) or GoodRx Holdings, Inc. (GDRX). But which o more_horizontal

The heavy selling pressure might have exhausted for GoodRx Holdings, Inc. (GDRX) as it is technically in oversold territory now. In addition to this t more_horizontal

Investors interested in stocks from the Medical Services sector have probably already heard of Icon PLC (ICLR) and GoodRx Holdings, Inc. (GDRX). But w more_horizontal

Investors looking for stocks in the Medical Services sector might want to consider either Icon PLC (ICLR) or GoodRx Holdings, Inc. (GDRX). But which o more_horizontal

While the top- and bottom-line numbers for GoodRx Holdings, Inc. (GDRX) give a sense of how the business performed in the quarter ended June 2023, it more_horizontal